ArticleThorax2006
Theophylline for COPD.
Article in Thorax, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed.
- Analysis of network expression and immune infiltration of disulfidptosis-related genes in chronic obstructive pulmonary disease.Immunity, inflammation and disease · 2024Article
- Verproside, the Most Active Ingredient in YPL-001 Isolated fromInternational journal of molecular sciences · 2023Article
- COPD disease knowledge, self-awareness and reasons for hospital presentations among a predominately Indigenous Australian cohort: a study to explore preventable hospitalisation.BMJ open respiratory research · 2022Article
- Article
- Systemic Inflammation in the Genesis of Frailty and Sarcopenia: An Overview of the Preventative and Therapeutic Role of Exercise and the Potential for Drug Treatments.Geriatrics (Basel, Switzerland) · 2017Review
- Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks.Molecules (Basel, Switzerland) · 2016Review
- Steroid Resistant CD8Frontiers in immunology · 2016Review
- Eosinophilic airway inflammation: role in asthma and chronic obstructive pulmonary disease.Therapeutic advances in chronic disease · 2016Review
- The Study of Efficacy, Tolerability and Safety of Theophylline Given Along with Formoterol Plus Budesonide in COPD.Journal of clinical and diagnostic research : JCDR · 2015Article
- Effects in cigarette smoke stimulated bronchial epithelial cells of a corticosteroid entrapped into nanostructured lipid carriers.Journal of nanobiotechnology · 2014Article
- The asthma-chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations.Expert review of clinical pharmacology · 2013Review
- [Alveolar epithelial cell injury as an etiopathogenic factor in pulmonary fibrosis].Archivos de bronconeumologia · 2012Review
- Nano-based theranostics for chronic obstructive lung diseases: challenges and therapeutic potential.Expert opinion on drug delivery · 2011Article
- Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler.International journal of nanomedicine · 2011Article
- Roflumilast, a Novel Phosphodiesterase 4 Inhibitor, for COPD Patients with a History of Exacerbations.Clinical medicine insights. Circulatory, respiratory and pulmonary medicine · 2011Article
- Theophylline.Pharmaceuticals (Basel, Switzerland) · 2010Review
- Increased FKBP51 in induced sputum cells of chronic obstructive pulmonary disease patients after therapy.European journal of medical research · 2009Article
- The efficacy and safety of cilomilast in COPD.Drugs · 2008Review
- Pharmacological treatment of chronic obstructive pulmonary disease.International journal of chronic obstructive pulmonary disease · 2006Review
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.